RAPT Therapeutics Inc (NASDAQ:RAPT) price on current trading day, rose 5.50% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.15.
A look at the stock’s price movement, the close in the last trading session was $1.09, moving within a range at $1.1 and $1.16. The beta value (5-Year monthly) was -0.308. Turning to its 52-week performance, $9.65 and $0.79 were the 52-week high and 52-week low respectively. Overall, RAPT moved -4.17% over the past month.
RAPT Therapeutics Inc’s market cap currently stands at around $151.81 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-05.
Turning to the stock’s technical picture we see that short term indicators suggest on average that RAPT is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
6 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 3 recommend RAPT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
RAPT’s current price about 0.44% and -3.43% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 49.52, while 7-day volatility ratio is 6.70% and 8.64% in the 30-day chart. Further, RAPT Therapeutics Inc (RAPT) has a beta value of -0.24, and an average true range (ATR) of 0.10. Analysts have given the company’s stock an average 52-week price target of $2, forecast between a low of $2 and high of $2. Looking at the price targets, the low is -73.91% off current price level while to achieve the yearly target high, price needs to move -73.91%. Nonetheless, investors will most likely welcome a -73.91% jump to $2 which is the analysts’ median price.
If we refocus on RAPT Therapeutics Inc (NASDAQ:RAPT), historical trading data shows that trading volumes averaged 0.6 over the past 10 days and 3.49 million over the past 3 months. The company’s latest data on shares outstanding shows there are 132.01 million shares.
The 47.81% of RAPT Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 45.20% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.63 million on 2025-02-28, giving us a short ratio of 4.67. The data shows that as of 2025-02-28 short interest in RAPT Therapeutics Inc (RAPT) stood at 213.99999999999997 of shares outstanding, with shares short rising to 2.57 million registered in 2025-01-31. Current price change has pushed the stock -27.22% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RAPT stock continues to rise going into the next quarter.
